ARROWHEAD RES CORP has a total of 148 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2000. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and macromolecular chemistry and polymers are MDRNA INC, INT STEM CELL CORP and FIT BIOTECH OYJ PLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 30 | |
#2 | EPO (European Patent Office) | 15 | |
#3 | WIPO (World Intellectual Property Organization) | 15 | |
#4 | Japan | 13 | |
#5 | Singapore | 10 | |
#6 | Republic of Korea | 9 | |
#7 | China | 8 | |
#8 | Mexico | 7 | |
#9 | South Africa | 6 | |
#10 | Canada | 5 | |
#11 | Brazil | 4 | |
#12 | Hong Kong | 4 | |
#13 | Israel | 4 | |
#14 | New Zealand | 4 | |
#15 | Chile | 3 | |
#16 | EAPO (Eurasian Patent Organization) | 2 | |
#17 | Peru | 2 | |
#18 | Taiwan | 2 | |
#19 | African Regional Industrial Property Organization | 1 | |
#20 | Argentina | 1 | |
#21 | Australia | 1 | |
#22 | Hungary | 1 | |
#23 | Serbia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Macromolecular chemistry and polymers | |
#4 | Organic fine chemistry | |
#5 | Machine tools | |
#6 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Wakefield Darren H | 51 |
#2 | Rozema David B | 50 |
#3 | Lewis David L | 37 |
#4 | Mohr Peter | 32 |
#5 | Hadwiger Philipp | 31 |
#6 | Blokhin Andrei V | 24 |
#7 | Kitas Eric A | 23 |
#8 | Hoffmann Torsten | 23 |
#9 | Carlson Jeffrey C | 23 |
#10 | Roehl Ingo | 22 |
Publication | Filing date | Title |
---|---|---|
TW201620526A | Compositions and methods for inhibiting gene expression of alpha-1 antitrypsin | |
US2015148402A1 | Modified small interfering RNA molecules and methods of use | |
US2014171487A1 | RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders | |
EP2807216A1 | Poly(vinyl ester) polymers for in vivo nucleic acid delivery | |
EP2838544A1 | Poly(acrylate) polymers for in vivo nucleic acid delivery | |
MX347298B | In vivo polynucleotide delivery conjugates having enzyme sensitive linkages. | |
CN103492568A | Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA | |
WO2012094115A1 | Compositions and methods for inhibiting expression of flt3 genes | |
WO2012082894A1 | Compositions and methods for inhibiting expression of mll genes | |
MX2012009178A | Compositions for targeted delivery of sirna. |